Free Webinar for ‘How to Care for Your Loved One with Cognitive Changes’ Hosted by the End Brain Cancer Initiative

Registration is now open for the Caregivers Self-Care and Tools online educational event, hosted by the End Brain Cancer Initiative (EBCI) on November 6th.

SEATTLE, WA, UNITED STATES, September 10, 2026 /EINPresswire.com/ — Registration is now open for the Caregivers Self-Care and Tools online educational event, hosted by the End Brain Cancer Initiative (EBCI) on November 6th, 2026, starting at 11 AM Pacific Time. This educational webinar is designed to provide caregivers with valuable tools, tips, and resources, while giving them the opportunity to hear from others who completely understand their story and journey.

The Keynote Speaker for this event is Dr. Jennifer Nosker, a clinical neuropsychologist and scientist at Brigham and Women’s Hospital and Instructor in Neurology at Harvard Medical School. She runs two clinics at the Center for Brain Mind Medicine, with her primary focus on patients diagnosed with primary and secondary brain tumors.

In her presentation on November 6th, Dr. Nosker will provide education to caregivers about the different types of cognitive changes that can occur in brain tumor patients, while simultaneously giving practical tools to help navigate these challenges. By teaching caregivers how cognition can be impacted and tools to navigate these challenges (i.e., memory compensatory strategies, etc.), it can help to normalize such difficulties, while also supporting daily functioning and quality of life

To attend this event, register for free at https://endbraincancer.org/caregiver-event-november-2026/.

Patient disease education event support and sponsorship is provided by Novocure, Harvard Medical School, Brigham and Women’s Hospital, CoeurCryo, and Great Purpose Productions.

About Novocure
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, pancreatic cancer, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non-small cell lung cancer and pancreatic cancer. For additional information about the company, please visit Novocure.com.

About the End Brain Cancer Initiative
The End Brain Cancer Initiative (EBCI) is a twenty-four-year-old 501(c)3 Non-Profit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving Standard of Care. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund (CEF), is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists, and clinical trial participation. We believe that IMMEDIATE ACCESS to these options provides this patient community with the best HOPE for survival and sustained quality of life. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers so they can have empowered conversations with their medical teams. Learn more about the End Brain Cancer Initiative or how to sponsor this annual campaign at EndBrainCancer.org.

To support the End Brain Cancer Initiative’s Programs & Services, including future educational events like this one, please consider making a $50 donation at https://endbraincancer.org/donate/.

Dellann Elliott Mydland, End Brain Cancer Initiative, 425-785-8489, Dellann@EndBrainCancer.org

Dellann Elliott Mydland
End Brain Cancer Initiative
+1 425-785-8489
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Media gallery